← back to search

John D. Potter

University of Washington Applied Physics Laboratory · US
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Centers & Research Units Partnerships Theses & Dissertations Community-Engaged Research Faculty Alumni Our Graduates Stay Connected Make a Gift News & Events In the News Epi Stories Events Epi Seminar Careers Jobs Opportunities Intranet Communications Resources Curriculum Resources Faculty Resources Fiscal Resources Travel Reimbursement Form" id="travel-reimbursement-form">> Travel Reimbursement Form Non-Travel Reimbursement Form" id="reimbursement-form">> Non-Travel Reimbursement Form Purchasing Form" id="purchasing-form">> Purchasing Form Health and Safety Resources IT Resources Space & Equipment Resources Staff Resources Faculty Menu About Our Staff
h-index
147
citations
85,040
works
1,282
NIH funding
primary concept
email

Recent publications

Subsequent primary cancer risks for non-hereditary colorectal cancer survivors
eClinicalMedicine 2026cited by 0position: contributordoi
Is health a basic human right or a commodity? Travelling the difficult road towards equity of outcomes. (2026 Mar 27) N Z Med J 139(1632) : 92-100 Bagshaw P, Potter JD, Goddard J, McDonald F, Bagshaw S, Roskruge M, Ahiro G
2026cited by 0position: selected
Subsequent primary cancer risks for non-hereditary colorectal cancer survivors. (2026 Feb) EClinicalMedicine 92() : 103716 Aung YK, Jenkins MA, Baxter NN, Potter JD, Schmit SL, Samadder JJ, Newcomb PA, Buchanan DD, Win AK
2026cited by 0position: selected
Associations of epidemiologic risk factors with Fusobacterium nucleatum and bacterial alpha diversity in the colorectal tumor-associated microbiota. (2026 Feb 10) Cancer Causes Control 37(3) : 45 Hill CM, Malen RC, Reedy AM, Kahsai O, Curtis K, Ma N, Randolph TW, Ma J, Thomas CE, Ogino S, Potter JD,
2026cited by 0position: selected
© 2026 University of Washington | Seattle, WA
2026cited by 0position: selected
Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors.
2025cited by 3position: contributordoi
Genetic risk factors modulate the association between physical activity and colorectal cancer
Research Square 2025cited by 1position: middledoi
Supplementary Figure S1 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025cited by 0position: contributordoi
Figure S7 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Data from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025cited by 0position: contributordoi
Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
2025cited by 0position: contributordoi
Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025cited by 0position: contributordoi
Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
2025cited by 0position: contributordoi
Data from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Figure S2 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Supplementary Figure S2 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Supplementary Methods from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Supplementary Figure S4 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025cited by 0position: contributordoi
Supplementary Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025cited by 0position: contributordoi
Figure S1 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Supplementary Figure S3 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Figure S3 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Table S5 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Table S4 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi
Supplementary Figure S5 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Supplementary Table S1 from Highly Sensitive DNA Testing of <i>Fusobacterium nucleatum</i> in Colorectal Tumors
2025cited by 0position: contributordoi
Figure S6 from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 51 papers (2019–2026)Shuji Ogino · Institute of Science Tokyo28 papers (2020–2025)Martha L. Slattery · Massachusetts General Hospital27 papers (2020–2023)Tabitha A. Harrison · Cancer Research Center22 papers (2020–2023)Martha L. Slattery · Massachusetts General Hospital21 papers (2012–2018)Lori C. Sakoda · Regeneron (United States)21 papers (2020–2023)Michael Hoffmeister · Festo (Germany)21 papers (2020–2023)Loı̈c Le Marchand · The London College20 papers (2012–2020)Mark Guinter · American Cancer Society20 papers (2020–2023)Sophia Harlid · John Wiley & Sons (United States)20 papers (2020–2023)Victor Moreno · Universidad de Sevilla20 papers (2020–2023)Polly A. Newcomb · University of Washington19 papers (2012–2019)Caroline Y. Um · Binus University19 papers (2020–2023)Heather Hampel · Ohio University19 papers (2020–2023)Akihisa Hidaka · Tokyo Yamate Medical Center19 papers (2020–2023)Wei Sun · Changzhou No.2 People's Hospital19 papers (2020–2023)Efrat Amitay · Boehringer Ingelheim (United States)19 papers (2020–2023)Bethany van Guelpen · Binus University19 papers (2020–2023)Daniel D. Buchanan · National Health and Medical Research Council19 papers (2020–2023)Ulrike Peters · Fred Hutch Cancer Center15 papers (2012–2018)